Form 4 · Filed Jun 23, 2026, 09:24 PM UTC
INDV/Indivior Pharmaceuticals, Inc.
Ciaffoni Joseph — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | M | other | 1,266,903 | — | — | 1,402,879 |
| Jun 22, 2026 | F | other | 612,549 | $38 | $23,472,878 | 790,330 |
| Jun 22, 2026 | M | other | 1,266,903 | — | — | 0 |
Source: SEC EDGAR raw filing ↗ · Accession 0001443841-26-000007